Patel HD, et al. - This study expounded the current utilization of retroperitoneal lymph node dissection (RPLND) for testicular seminomas by stage and the implications for survival. The yielded data illustrated stability in the utilization of RPLND in the post-chemotherapy setting, over a 25-year period. Patients undergoing RPLND were at a greater risk. Nonetheless, stage-by-stage survival outcomes appeared comparable to men not undergoing RPLND. Upcoming trials implementing RPLND as the first-line modality for testicular seminoma or isolated retroperitoneal relapse would assist in an improved quantification of the relative recurrence and survival.